These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 5546127)

  • 1. [Influence of growth hormone on hydroxyprolinuria in patients with pituitary dwarfism].
    Kopecký A
    Endokrinologie; 1971; 57(2):194-200. PubMed ID: 5546127
    [No Abstract]   [Full Text] [Related]  

  • 2. Dwarfism with elevated levels of plasma growth hormone.
    Najjar SS; Khachadurian AK; Ilbawi MN; Blizzard RM
    N Engl J Med; 1971 Apr; 284(15):809-12. PubMed ID: 5549802
    [No Abstract]   [Full Text] [Related]  

  • 3. [The urinary hydroxyproline-creatinine ratio, in random samples, in normal children and pituitary dwarfs].
    Klain U; Cicchiello V; Scarcella A; Nocerino P; Chianese A; De Curtis M; De Curtis D
    Pediatria (Napoli); 1980 Jun; 88(2):218-27. PubMed ID: 7243518
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pituitary dwarfism due to peripheral resistance to somatotropic hormone].
    Boscherini B
    Minerva Pediatr; 1976 May; 28(18):1093-4. PubMed ID: 1012183
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hydroxyprolinuria test. Its use for the diagnosis of pituitary dwarfism caused by peripheral resistance].
    Carratù A; Mancuso G; Pasquino A; Coppola L; Randone G; Boscherini B
    Minerva Pediatr; 1975 May; 27(17):1014-9. PubMed ID: 1134459
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of pituitary dwarfism with human growth hormone in the course of 3 years].
    Bittel-Dobrzyńska N; Dorant B
    Pediatr Pol; 1977 Aug; 52(8):845-51. PubMed ID: 904989
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term treatment with human growth hormone (Raben) in small doses. Evaluation of 18 hypopituitary patients.
    Prader A; Zachmann M; Poley JR; Illig R; Széky J
    Helv Paediatr Acta; 1967 Oct; 22(5):423-40. PubMed ID: 5595745
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydroxyproline excretion in pituitary dwarfs treated with therapeutic doses of human growth hormone.
    Batrinos ML; Grispos GE; Papadopoulou ZP; Varonos DD
    Horm Res; 1973; 4(5):311-20. PubMed ID: 4755421
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydroxyproline excretion in various forms of growth failure.
    Teller WM; Genscher U; Burkhardt H; Rommel K
    Arch Dis Child; 1973 Feb; 48(2):127-32. PubMed ID: 4690509
    [No Abstract]   [Full Text] [Related]  

  • 10. The results of treatment of pituitary dwarfism with human growth hormone (author's transl).
    Lenartowska I; Doliwa-Taborska J; Raczyńska B; Swiecicki A
    Probl Med Wieku Rozwoj; 1972; 1():111-9. PubMed ID: 4680543
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pituitary dwarfism. Our experience with human growth hormone treatment].
    Sanz Moreno J; López-Linares M; Arrieta F; Ramos F; Herrera Pombo JL
    Rev Clin Esp; 1981 Oct; 163(2):105-10. PubMed ID: 7330341
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of the administration of human growth hormone on L-proline tolerance in pituitary dwarfism].
    Florea I; Popa M; Ionescu V; Dinulescu E; Ganea E
    Stud Cercet Endocrinol; 1971; 22(6):455-8. PubMed ID: 5135422
    [No Abstract]   [Full Text] [Related]  

  • 13. [Initial results in the treatment of pituitary dwarfism using growth hormone].
    Moncada Lorenzo E; Barbería Layana JJ; Morant Ciscar JA; Serrano Martinez M
    Rev Med Univ Navarra; 1975; 19(1):49-61. PubMed ID: 1234782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proceedings: Treatment of pituitary dwarfism].
    Ichikawa K; Idemura R; Takano K; Odagiri E; Maeda T
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):629. PubMed ID: 4476623
    [No Abstract]   [Full Text] [Related]  

  • 15. Isolated human growth hormone deficiency. IV. The response of sexual ateliotic dwards to exogenous growth hormone.
    Merimee TJ; Rabinowitz D; Hall J; Rimoin DL; McKusick VA
    Metabolism; 1968 Nov; 17(11):1012-8. PubMed ID: 5724164
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary hydroxyproline in children with growth hormone deficiency. Clinical value in diagnosis and prognosis.
    Wharton BA; Brown G; Raynor PH; Howells G; Pennock CA
    Arch Dis Child; 1974 Feb; 49(2):159-62. PubMed ID: 4817449
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of pituitary nanism with human growth hormone. Indications, methods and results, perspectives].
    Job JC
    Ann Pediatr (Paris); 1985 Feb; 32(2):85-92. PubMed ID: 3977234
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dynamics of the bio-electric activity of brain in patients with pituitary dwarfism during the treatment with human growth hormone (author's transl)].
    Koślacz-Folga A; Lenartowska I
    Probl Med Wieku Rozwoj; 1972; 1():131-45. PubMed ID: 4680545
    [No Abstract]   [Full Text] [Related]  

  • 19. [Our experience in the substitution treatment of pituitary dwarfism].
    Aicardi G; Naselli A; Cavaliere G
    Minerva Pediatr; 1976 May; 28(18):1088-92. PubMed ID: 1012182
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the therapy of hypophyseal dwarfism using the somatotropic hormone].
    Knappe G
    Z Gesamte Inn Med; 1968 Sep; 23(17):Suppl:259-61. PubMed ID: 5728039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.